A proposed update of the Coordinated Framework for the Regulation of Biotechnology falls far short of changes needed with regard to ensuring the global marketability of bioengineered crops, according to leading U.S. grain groups.
Objections to the proposed changes are expressed in a November letter … signed by leaders of the North American Millers’ Association, the North American Export Grain Association, the National Grain and Feed Association and the Corn Refiners Association.
Because of a variety of challenges, including intermittent disruptions in global trade, the groups urge the inter-agency committee to consider the establishment of a “conditional deregulation” designation for biotechnology traits demonstrated to be safe but that have not yet received approvals in “significant U.S. export markets.”
The groups strongly support the importance of biotechnology in crop production.
. . . .
“What is of overriding importance in our view are the serious issues related to the marketability and current lack of international regulatory coherence regarding the premarket regulatory review of crops produced through modern biotechnology, and the negative impact those factors have in facilitating access to U.S. crops,” the groups noted.
The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. Read full, original post: Biotechnology Coordinated Framework update seen falling short in key areas
